| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0008 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0008 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |